Search Result "Fosamprenavir"
Determination and Validation of the Antiviral Drugs Using Reverse Phase High Performance Liquid Chromatographic Method
Journal: Current Drug Therapy
Volume: 9 Issue: 4 Year: 2014 Page: 256-260
Author(s): Sevinc Kurbanoglu,Amir M. Ashrafi,Karel Vytras,Bengi Uslu,Sibel A. Ozkan
Discovery of Next Generation Inhibitors of HIV Protease
Journal: Current Topics in Medicinal Chemistry
Volume: 5 Issue: 1 Year: 2005 Page: 1589-1607
Author(s): Andrew Spaltenstein, Wieslaw M. Kazmierski, John F. Miller, Vicente Samano
Inhibitors of HIV-1 Protease: Current State of the Art 10 Years After their Introduction. From Antiretroviral Drugs to Antifungal, Antibacterial and Antitumor Agents Based on Aspartic Protease Inhibitors
Journal: Current Medicinal Chemistry
Volume: 14 Issue: 2 Year: 2007 Page: 2734-2748
Author(s): Antonio Mastrolorenzo, Stefano Rusconi, Andrea Scozzafava, Giuseppe Barbaro, Claudiu T. Supuran
Current Development on HIV-1 Protease Inhibitors
Journal: Current Computer-Aided Drug Design
Volume: 3 Issue: 3 Year: 2007 Page: 201-213
Author(s): Ornjira Aruksakunwong, Siriporn Promsri, Kitiyaporn Wittayanarakul, Piyarat Nimmanpipug, Vannajan S. Lee, Atchara Wijitkosoom, Pornthep Sompornpisut, Supot Hannongbua
Impact of Age and Gender Disparity on CD4+ Cell Counts to ControlDisease Progression Using Specific HAART in HIV-1 Positive Patients: ACase-Control Study
Journal: Reviews on Recent Clinical Trials
Volume: 17 Issue: 3 Year: 2022 Page: 195-207
Author(s): Ashok K. Singh
Evaluation of Treatment Tolerability, Satisfaction and Laboratory Parameters in HIV+ Patients Switching from Ritonavir Capsule to Tablet Formulation§
Journal: Current HIV Research
Volume: 11 Issue: 3 Year: 2013 Page: 231-237
Author(s): Andy Mtambo,Marianne Harris,Junine Toy,Silvia Guillemi,Wendy Zhang,Viviane. D. Lima,Robert Hogg,Julio S.G. Montaner,Mark Hull
The Current Progress and Challenge in the Development of Protease Inhibitors of HIV-1
Ebook: Frontiers in Clinical Drug Research: HIV
Volume: 3 Year: 2016
Author(s): Chang Liu,Xiaohong Kong
Doi: 10.2174/9781681082295116030009
Prodrugs of HIV Protease Inhibitors
Journal: Current Pharmaceutical Design
Volume: 9 Issue: 2 Year: 2003 Page: 1755-1770
Author(s): Pierre Vierling, Jacques Greiner
HIV Protease Inhibitors - The Next Generation
Journal: Current Medicinal Chemistry - Anti-Infective Agents
Volume: 1 Issue: 2 Year: 2002 Page: 141-162
Author(s): Steve R. Turner
Therapeutic Drug Monitoring: A Tool to Individualize Highly Active Antiretroviral Therapy in HIV Infected Patients
Journal: Current Pharmaceutical Analysis
Volume: 2 Issue: 3 Year: 2006 Page: 205-217
Author(s): Peter Langmann, Michael Zilly, Ralf Winzer, Hartwig Klinker